资讯

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy ...
The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...
Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.
Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their investigational products. Though the process to phase out animal testing will begin ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
The Food and Drug Administration on Thursday said it would begin phasing out animal testing requirements for antibody ...